ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial
David A. Drew(Massachusetts General Hospital), Andrew T. Chan(Harvard University), Curtis Huttenhower(Harvard University), Peter J. Carolan, Hamed Khalili(Harvard University), Kathleen O. Stewart(Harvard University), John J. Garber(Grand Rapids Community College), Katherine K. Gilpin(Harvard University), Dmitriy Kedrin(Allen Institute), M Parziale(Harvard University), Ginger L. Milne(Vanderbilt University), Sanford D. Markowitz(Howard Hughes Medical Institute), Samantha M. Chin(Washington University in St. Louis), Francis Colizzo, Emily N. Pond(Harvard University), Meaghan Flagg(Ragon Institute of MGH, MIT and Harvard), Crystal A. Rawlings(Ragon Institute of MGH, MIT and Harvard), Manish Gala(Harvard University), Kyle Staller(Massachusetts General Hospital), Matthew L. Freedman(Brigham and Women's Hospital), Daniel C. Chung(Massachusetts General Hospital), Douglas S. Kwon(Ragon Institute of MGH, MIT and Harvard), Hemant K. Roy(Boston University), Molin Wang(Cancer Research And Biostatistics), Norman S. Nishioka(Harvard University), James M. Richter(Brigham and Women's Hospital), Madeline M. Schuck(Harvard University), Vadim Backman(Unknown)
Cited by 40
Related Papers
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
|Nature Biotechnology|2019|24.2k
Metagenomic biomarker discovery and explanation
|Genome biology|2011|16.7k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
|Science|2006|3.2k